Erythropoietin treatment for anemia in end-stage renal disease with diabetes mellitus.
Nakatsuka
K
K
Hino
M
M
Miki
T
T
Nishizawa
Y
Y
Tabata
T
T
Inoue
T
T
Morii
H
H
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D003928:Diabetic Nephropathies / Q000097:blood / Q000628:therapy*; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
D004921:Erythropoietin; D006442:Glycated Hemoglobin; D011994:Recombinant Proteins